Ling Su
6PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 14, 2025
Real-world pharmacovigilance study on neonatal congenital anomalies associated with maternal drug exposure using the FDA Adverse Event Reporting System.Jingping Zheng, Zhenpo Zhang, Lin Ma
|Sep 18, 2025
Adverse Events Associated With Dabrafenib, Trametinib, and Their Combination Therapy: A Disproportionality Analysis of the FDA Adverse Event Reporting System (FAERS) Database.Zhenpo Zhang, Qimin Wu, Yuting Wang
|Jan 06, 2025
Age-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System.Haiyan Mai, Zhenpo Zhang, Yankun Liang
|Dec 22, 2024
Risk of congenital anomalies associated with psychotropic medications: a review of neonatal reports in the FDA adverse event reporting System (FAERS).Jingping Zheng, Zhenpo Zhang, Yankun Liang
|Dec 13, 2024
Congenital anomalies associated with the use of cardiovascular drugs during pregnancy: a large-scale data analysis from the FAERS database.Jingping Zheng, Lin Ma, Zhenpo Zhang
|Oct 15, 2024
Association of incretin-based therapies with hepatobiliary disorders among patients with type 2 diabetes: a case series from the FDA adverse event reporting system.Yankun Liang, Zhenpo Zhang, Jingping Zheng
Pageof 1
